id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02880215
|
28:50:chronic_disease
|
meets criteria for current substance use disorder (mild or greater severity)
| 3
|
[
"meets",
"criteria",
"for",
"current",
"substance",
"use",
"disorder",
"(",
"mild",
"or",
"greater",
"severity",
")"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02404155
|
1:29:chronic_disease
|
Systemic Lupus Erythematosus
| 3
|
[
"Systemic",
"Lupus",
"Erythematosus"
] |
[
2,
2,
2
] |
NCT02577406
|
29:51:treatment,59:75:treatment,93:97:chronic_disease
|
The use of a stable dose of oral steroid post-HSCT and/or topical steroids for ongoing skin GVHD
| 3
|
[
"The",
"use",
"of",
"a",
"stable",
"dose",
"of",
"oral",
"steroid",
"post-HSCT",
"and/or",
"topical",
"steroids",
"for",
"ongoing",
"skin",
"GVHD"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
2
] |
NCT02525692
|
,,24:30:treatment,73:84:treatment,209:218:treatment
|
Pregnant women because ONC201 is novel agent with unknown potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with ONC201, breastfeeding should be discontinued if the mother is treated with ONC201
| 3
|
[
"Pregnant",
"women",
"because",
"ONC201",
"is",
"novel",
"agent",
"with",
"unknown",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects",
".",
"Because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"for",
"adverse",
"events",
"in",
"nursing",
"infants",
"secondary",
"to",
"treatment",
"of",
"the",
"mother",
"with",
"ONC201",
",",
"breastfeeding",
"should",
"be",
"discontinued",
"if",
"the",
"mother",
"is",
"treated",
"with",
"ONC201"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02681211
|
23:46:treatment,58:67:treatment,77:83:treatment
|
Patients who received ED migraine medications (including ibuprofen or other NSAIDS) prior to study evaluation
| 3
|
[
"Patients",
"who",
"received",
"ED",
"migraine",
"medications",
"(",
"including",
"ibuprofen",
"or",
"other",
"NSAIDS",
")",
"prior",
"to",
"study",
"evaluation"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00871260
|
1:32:chronic_disease
|
Second or third degree AV block
| 3
|
[
"Second",
"or",
"third",
"degree",
"AV",
"block"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT03124355
|
6:42:chronic_disease,,,,159:182:chronic_disease,,263:286:chronic_disease
|
with Postural Tachycardia Syndrome (POTS) as defined by a heart rate increase ≥30 bpm from supine within 10 min of standing or head-up tilt in the absence of orthostatic hypotension, with chronic symptoms (> 6 months), and in the absence of other acute cause of orthostatic tachycardia
| 3
|
[
"with",
"Postural",
"Tachycardia",
"Syndrome",
"(",
"POTS",
")",
"as",
"defined",
"by",
"a",
"heart",
"rate",
"increase",
"≥30",
"bpm",
"from",
"supine",
"within",
"10",
"min",
"of",
"standing",
"or",
"head-up",
"tilt",
"in",
"the",
"absence",
"of",
"orthostatic",
"hypotension",
",",
"with",
"chronic",
"symptoms",
"(",
">",
"6",
"months",
")",
",",
"and",
"in",
"the",
"absence",
"of",
"other",
"acute",
"cause",
"of",
"orthostatic",
"tachycardia"
] |
[
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02541903
|
1:25:cancer
|
Meningeal carcinomatosis
| 3
|
[
"Meningeal",
"carcinomatosis"
] |
[
3,
3
] |
NCT02252432
|
35:44:treatment,57:78:treatment,85:97:treatment,99:109:treatment,111:121:treatment,123:135:treatment,137:153:treatment
|
Drugs/substances known to inhibit methadone metabolism: macrolide antibiotics e.g., erythromycin, cimetidine, astemizole, voriconazole, grapefruit juice
| 3
|
[
"Drugs/substances",
"known",
"to",
"inhibit",
"methadone",
"metabolism",
":",
"macrolide",
"antibiotics",
"e.g.",
",",
"erythromycin",
",",
"cimetidine",
",",
"astemizole",
",",
"voriconazole",
",",
"grapefruit",
"juice"
] |
[
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1
] |
NCT02397083
|
42:52:allergy_name,62:71:allergy_name,86:95:allergy_name,97:109:allergy_name
|
Known intolerance or hypersensitivity to everolimus or other rapamycin analogs (e.g. sirolimus, temsirolimus)
| 3
|
[
"Known",
"intolerance",
"or",
"hypersensitivity",
"to",
"everolimus",
"or",
"other",
"rapamycin",
"analogs",
"(",
"e.g",
".",
"sirolimus",
",",
"temsirolimus",
")"
] |
[
0,
0,
0,
0,
0,
4,
0,
0,
4,
0,
0,
0,
0,
4,
0,
4,
0
] |
NCT02631850
|
93:106:chronic_disease,,128:136:chronic_disease,151:182:chronic_disease
|
Have medical conditions that would place volunteers at higher risk of adverse events (e.g., renal disease, frailty, pregnancy, dementia, severe pain, end-stage/degenerative diseases)
| 3
|
[
"Have",
"medical",
"conditions",
"that",
"would",
"place",
"volunteers",
"at",
"higher",
"risk",
"of",
"adverse",
"events",
"(",
"e.g.",
",",
"renal",
"disease",
",",
"frailty",
",",
"pregnancy",
",",
"dementia",
",",
"severe",
"pain",
",",
"end-stage/degenerative",
"diseases",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0
] |
NCT01676259
|
4:18:cancer
|
nonadenocarcinoma histology
| 3
|
[
"nonadenocarcinoma",
"histology"
] |
[
3,
3
] |
NCT00673842
|
1:22:chronic_disease,24:36:treatment,40:59:treatment
|
Chronic renal failure (hemodialysis or peritoneal dialysis)
| 3
|
[
"Chronic",
"renal",
"failure",
"(",
"hemodialysis",
"or",
"peritoneal",
"dialysis",
")"
] |
[
2,
2,
2,
0,
1,
0,
1,
1,
0
] |
NCT02520427
|
,,,98:108:treatment
|
Women planning to become pregnant while on study through 1 week after receiving the last dose of study drug
| 3
|
[
"Women",
"planning",
"to",
"become",
"pregnant",
"while",
"on",
"study",
"through",
"1",
"week",
"after",
"receiving",
"the",
"last",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02132598
|
34:52:cancer,66:82:cancer,105:114:treatment
|
Previously treated patients with non-squamous NSCLC who have had brain metastases at any point in their treatment history
| 3
|
[
"Previously",
"treated",
"patients",
"with",
"non-squamous",
"NSCLC",
"who",
"have",
"had",
"brain",
"metastases",
"at",
"any",
"point",
"in",
"their",
"treatment",
"history"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
1,
0
] |
NCT02440815
|
1:15:treatment,23:36:treatment,,64:89:treatment,
|
Antidepressant use or psychotherapy within the past 6 weeks or electroconvulsive therapy within the past 6 months
| 3
|
[
"Antidepressant",
"use",
"or",
"psychotherapy",
"within",
"the",
"past",
"6",
"weeks",
"or",
"electroconvulsive",
"therapy",
"within",
"the",
"past",
"6",
"months"
] |
[
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01810588
|
1:29:chronic_disease
|
Chronic lymphocytic leukemia, relapsed or with poor prognostic features
| 3
|
[
"Chronic",
"lymphocytic",
"leukemia",
",",
"relapsed",
"or",
"with",
"poor",
"prognostic",
"features"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02106052
|
1:3:chronic_disease,
|
MS diagnosis at least 6 months prior
| 3
|
[
"MS",
"diagnosis",
"at",
"least",
"6",
"months",
"prior"
] |
[
2,
0,
0,
0,
0,
0,
0
] |
NCT01925573
|
22:42:allergy_name
|
Known sensitivity to conductive hydrogels
| 3
|
[
"Known",
"sensitivity",
"to",
"conductive",
"hydrogels"
] |
[
0,
0,
0,
4,
4
] |
NCT02158858
|
,,82:94:treatment,
|
Platelet count ≥ 75 x 10^9/L without the assistance of thrombopoietic factors or transfusions for at least 14 days
| 3
|
[
"Platelet",
"count",
"≥",
"75",
"x",
"10^9/L",
"without",
"the",
"assistance",
"of",
"thrombopoietic",
"factors",
"or",
"transfusions",
"for",
"at",
"least",
"14",
"days"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02234934
|
1:11:chronic_disease
|
Infectious
| 3
|
[
"Infectious"
] |
[
2
] |
NCT03043807
|
1:17:treatment,24:34:treatment,36:45:treatment,47:58:treatment,60:69:treatment
|
Hormonal therapy (e.g. leuprolide, goserelin, triptorelin, degarelix)
| 3
|
[
"Hormonal",
"therapy",
"(",
"e.g",
".",
"leuprolide",
",",
"goserelin",
",",
"triptorelin",
",",
"degarelix",
")"
] |
[
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02667392
|
,,22:39:chronic_disease
|
> 6 months < 5 years post-stroke onset
| 3
|
[
">",
"6",
"months",
"<",
"5",
"years",
"post-stroke",
"onset"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03017196
|
53:71:chronic_disease
|
Health professionals who do not treat patients with chronic conditions
| 3
|
[
"Health",
"professionals",
"who",
"do",
"not",
"treat",
"patients",
"with",
"chronic",
"conditions"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02203513
|
,,200:220:treatment
|
all subjects of reproductive potential must agree to use adequate contraception prior to study entry, for the duration of study participation, and for at least four months following the last dose of experimental therapy
| 3
|
[
"all",
"subjects",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"prior",
"to",
"study",
"entry",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"at",
"least",
"four",
"months",
"following",
"the",
"last",
"dose",
"of",
"experimental",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02925923
|
12:27:treatment,29:40:treatment,42:51:treatment,
|
use of any thienopyridines (Clopidogrel, Prasugrel) 7 days prior to randomization
| 3
|
[
"use",
"of",
"any",
"thienopyridines",
"(",
"Clopidogrel",
",",
"Prasugrel",
")",
"7",
"days",
"prior",
"to",
"randomization"
] |
[
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02193191
|
1:14:treatment,
|
Major surgery in the past 30 days
| 3
|
[
"Major",
"surgery",
"in",
"the",
"past",
"30",
"days"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT02327403
|
13:37:treatment,39:51:treatment,55:65:treatment
|
Maintenance immunosuppression of CNI (cyclosporine or tacrolimus)
| 3
|
[
"Maintenance",
"immunosuppression",
"of",
"CNI",
"(",
"cyclosporine",
"or",
"tacrolimus",
")"
] |
[
0,
1,
1,
1,
0,
1,
0,
1,
0
] |
NCT01954576
|
71:83:treatment,286:294:treatment,296:313:treatment,319:333:treatment,404:419:treatment,455:460:cancer
|
There must be an interval of at least 12 weeks from the completion of radiotherapy to start of device treatment. When the interval is less than 12 weeks from the completion of radiotherapy, the histological confirmation of progression must be unequivocal per RANO criteria. The use of PET scan, perfusion imaging, and MRspectroscopy to differentiate between true early progression and pseudoprogression prior to biopsy or resection of probable recurrent tumor is per standard of care
| 3
|
[
"There",
"must",
"be",
"an",
"interval",
"of",
"at",
"least",
"12",
"weeks",
"from",
"the",
"completion",
"of",
"radiotherapy",
"to",
"start",
"of",
"device",
"treatment",
".",
"When",
"the",
"interval",
"is",
"less",
"than",
"12",
"weeks",
"from",
"the",
"completion",
"of",
"radiotherapy",
",",
"the",
"histological",
"confirmation",
"of",
"progression",
"must",
"be",
"unequivocal",
"per",
"RANO",
"criteria",
".",
"The",
"use",
"of",
"PET",
"scan",
",",
"perfusion",
"imaging",
",",
"and",
"MRspectroscopy",
"to",
"differentiate",
"between",
"true",
"early",
"progression",
"and",
"pseudoprogression",
"prior",
"to",
"biopsy",
"or",
"resection",
"of",
"probable",
"recurrent",
"tumor",
"is",
"per",
"standard",
"of",
"care"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02725177
|
14:22:chronic_disease,24:36:chronic_disease,88:103:treatment
|
Uncontrolled diabetes, hypertension, or other contra-indication to increased dosage of glucocorticoids
| 3
|
[
"Uncontrolled",
"diabetes",
",",
"hypertension",
",",
"or",
"other",
"contra-indication",
"to",
"increased",
"dosage",
"of",
"glucocorticoids"
] |
[
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02706249
|
1:25:chronic_disease
|
Congestive heart failure (NYHA class III or IV)
| 3
|
[
"Congestive",
"heart",
"failure",
"(",
"NYHA",
"class",
"III",
"or",
"IV",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03154476
|
1:33:chronic_disease
|
Pulmonary veno-occlusive disease
| 3
|
[
"Pulmonary",
"veno-occlusive",
"disease"
] |
[
2,
2,
2
] |
NCT01726257
|
1:19:chronic_disease
|
Aneurysmal disease of the descending thoracic aorta
| 3
|
[
"Aneurysmal",
"disease",
"of",
"the",
"descending",
"thoracic",
"aorta"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT01625923
|
44:75:chronic_disease,,124:140:treatment,142:163:treatment,165:177:treatment,180:194:treatment
|
Use of medications potentially influencing upper gastrointestinal motility or appetite within one week of the study (e.g., prokinetic drugs, macrolide antibiotics (erythromycin), GLP-1 mimetics)
| 3
|
[
"Use",
"of",
"medications",
"potentially",
"influencing",
"upper",
"gastrointestinal",
"motility",
"or",
"appetite",
"within",
"one",
"week",
"of",
"the",
"study",
"(",
"e.g.",
",",
"prokinetic",
"drugs",
",",
"macrolide",
"antibiotics",
"(",
"erythromycin",
")",
",",
"GLP-1",
"mimetics",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0
] |
NCT03099070
|
1:26:chronic_disease
|
Axis-I psychotic disorder
| 3
|
[
"Axis-I",
"psychotic",
"disorder"
] |
[
2,
2,
2
] |
NCT02770326
|
8:15:chronic_disease
|
Active fistula
| 3
|
[
"Active",
"fistula"
] |
[
0,
2
] |
NCT02588326
|
22:31:chronic_disease
|
History of recurrent epistaxis, or any epistaxis requiring medical intervention
| 3
|
[
"History",
"of",
"recurrent",
"epistaxis",
",",
"or",
"any",
"epistaxis",
"requiring",
"medical",
"intervention"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02355912
|
1:21:treatment
|
pace maker placement
| 3
|
[
"pace",
"maker",
"placement"
] |
[
1,
1,
1
] |
NCT02311621
|
141:163:treatment
|
Presence of any concurrent medical condition that, in the opinion of the protocol PI or designee, would prevent the patient from undergoing protocol-based therapy
| 3
|
[
"Presence",
"of",
"any",
"concurrent",
"medical",
"condition",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"protocol",
"PI",
"or",
"designee",
",",
"would",
"prevent",
"the",
"patient",
"from",
"undergoing",
"protocol-based",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02547818
|
14:23:allergy_name,25:31:allergy_name,33:40:allergy_name,42:49:allergy_name,60:67:allergy_name
|
Allergies to ibuprofen (Advil®, Motrin®, Nuprin®, etc.) or aspirin
| 3
|
[
"Allergies",
"to",
"ibuprofen",
"(",
"Advil®",
",",
"Motrin®",
",",
"Nuprin®",
",",
"etc",
".",
")",
"or",
"aspirin"
] |
[
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4,
4
] |
NCT03113136
|
25:47:chronic_disease
|
unstable or significant psychiatric conditions (past and stable conditions will be allowed)
| 3
|
[
"unstable",
"or",
"significant",
"psychiatric",
"conditions",
"(",
"past",
"and",
"stable",
"conditions",
"will",
"be",
"allowed",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02210650
|
31:73:treatment,94:105:treatment,109:111:treatment
|
Patients scheduled to undergo ureteroscopic removal of ureteral stone(s) that are visible on KUB (x-ray) or CT (i.e., calcium stones)
| 3
|
[
"Patients",
"scheduled",
"to",
"undergo",
"ureteroscopic",
"removal",
"of",
"ureteral",
"stone",
"(",
"s",
")",
"that",
"are",
"visible",
"on",
"KUB",
"(",
"x-ray",
")",
"or",
"CT",
"(",
"i.e.",
",",
"calcium",
"stones",
")"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02770326
|
1:27:chronic_disease
|
Inflammatory bowel disease
| 3
|
[
"Inflammatory",
"bowel",
"disease"
] |
[
2,
2,
2
] |
NCT02088554
|
,20:33:chronic_disease
|
Child-Pugh Class C liver disease
| 3
|
[
"Child-Pugh",
"Class",
"C",
"liver",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02286687
|
,,59:61:treatment,,104:125:treatment,137:176:treatment,172:175:treatment,224:238:treatment,
|
International normalized ratio (INR) or prothrombin time (PT) =< 1.5 x ULN unless subject is receiving anticoagulant therapy as long as PT or partial thromboplastin time (PTT) is within therapeutic range of intended use of anticoagulants; activated PTT (aPTT) =< 1.5 x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
| 3
|
[
"International",
"normalized",
"ratio",
"(",
"INR",
")",
"or",
"prothrombin",
"time",
"(",
"PT",
")",
"=",
"<",
"1.5",
"x",
"ULN",
"unless",
"subject",
"is",
"receiving",
"anticoagulant",
"therapy",
"as",
"long",
"as",
"PT",
"or",
"partial",
"thromboplastin",
"time",
"(",
"PTT",
")",
"is",
"within",
"therapeutic",
"range",
"of",
"intended",
"use",
"of",
"anticoagulants",
";",
"activated",
"PTT",
"(",
"aPTT",
")",
"=",
"<",
"1.5",
"x",
"ULN",
"unless",
"subject",
"is",
"receiving",
"anticoagulant",
"therapy",
"as",
"long",
"as",
"PT",
"or",
"PTT",
"is",
"within",
"therapeutic",
"range",
"of",
"intended",
"use",
"of",
"anticoagulants"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02762006
|
12:39:treatment,,,107:117:treatment,121:133:treatment
|
Receipt of live attenuated vaccination within 30 days prior to study entry or within 30 days of receiving durvalumab or tremelimumab
| 3
|
[
"Receipt",
"of",
"live",
"attenuated",
"vaccination",
"within",
"30",
"days",
"prior",
"to",
"study",
"entry",
"or",
"within",
"30",
"days",
"of",
"receiving",
"durvalumab",
"or",
"tremelimumab"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT03100539
|
1:18:chronic_disease,
|
Chronic neck pain for 6 months or longer
| 3
|
[
"Chronic",
"neck",
"pain",
"for",
"6",
"months",
"or",
"longer"
] |
[
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT03148795
|
13:18:chronic_disease,20:27:chronic_disease,32:61:chronic_disease
|
Significant renal, hepatic, or bone marrow organ dysfunction
| 3
|
[
"Significant",
"renal",
",",
"hepatic",
",",
"or",
"bone",
"marrow",
"organ",
"dysfunction"
] |
[
0,
2,
0,
2,
0,
0,
2,
2,
2,
2
] |
NCT02338232
|
39:51:chronic_disease,52:62:treatment,,123:134:treatment
|
Patient unable to discontinue current hypertension medication for medical or other reasons for two days prior to starting telmisartan
| 3
|
[
"Patient",
"unable",
"to",
"discontinue",
"current",
"hypertension",
"medication",
"for",
"medical",
"or",
"other",
"reasons",
"for",
"two",
"days",
"prior",
"to",
"starting",
"telmisartan"
] |
[
0,
0,
0,
0,
0,
2,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01812174
|
15:30:chronic_disease
|
Patients with aortic aneurysm or other medical condition that creates a higher than usual risk of surgical complication
| 3
|
[
"Patients",
"with",
"aortic",
"aneurysm",
"or",
"other",
"medical",
"condition",
"that",
"creates",
"a",
"higher",
"than",
"usual",
"risk",
"of",
"surgical",
"complication"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02719847
|
39:64:treatment,66:78:treatment,80:98:treatment,100:115:treatment,120:127:treatment
|
Patients already scheduled to receive conventional radiotherapy, chemotherapy, biological therapy, vaccine therapy, or surgery as treatment
| 3
|
[
"Patients",
"already",
"scheduled",
"to",
"receive",
"conventional",
"radiotherapy",
",",
"chemotherapy",
",",
"biological",
"therapy",
",",
"vaccine",
"therapy",
",",
"or",
"surgery",
"as",
"treatment"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
1,
0,
0
] |
NCT02864277
|
33:55:cancer,67:74:cancer,76:87:cancer,93:109:cancer
|
Known or suspected diagnosis of gynecologic malignancy (including ovarian, endometrial, and cervical cancers)
| 3
|
[
"Known",
"or",
"suspected",
"diagnosis",
"of",
"gynecologic",
"malignancy",
"(",
"including",
"ovarian",
",",
"endometrial",
",",
"and",
"cervical",
"cancers",
")"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
3,
0,
0,
3,
3,
0
] |
NCT01604512
|
25:28:treatment,36:45:treatment,47:60:treatment,62:77:treatment
|
Any contraindication to MRI (e.g., pacemaker, aneurysm clip, tissue expander)
| 3
|
[
"Any",
"contraindication",
"to",
"MRI",
"(",
"e.g.",
",",
"pacemaker",
",",
"aneurysm",
"clip",
",",
"tissue",
"expander",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0
] |
NCT02177695
|
12:35:chronic_disease
|
Documented muscle invasive disease
| 3
|
[
"Documented",
"muscle",
"invasive",
"disease"
] |
[
0,
2,
2,
2
] |
NCT02532231
|
,,151:174:treatment
|
Males who have partners of childbearing potential must agree to use an effective contraceptive method during the study and for 31 weeks following the last dose of study drug
| 3
|
[
"Males",
"who",
"have",
"partners",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"use",
"an",
"effective",
"contraceptive",
"method",
"during",
"the",
"study",
"and",
"for",
"31",
"weeks",
"following",
"the",
"last",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02108860
|
14:33:chronic_disease,
|
A history of active tuberculosis within the past 3 years even if treated
| 3
|
[
"A",
"history",
"of",
"active",
"tuberculosis",
"within",
"the",
"past",
"3",
"years",
"even",
"if",
"treated"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01822522
|
,,,192:202:treatment
|
all participants of reproductive potential must agree to use both a barrier method and a second method of birth control during the course of the study and for 6 months after the last dose of study drug
| 3
|
[
"all",
"participants",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"both",
"a",
"barrier",
"method",
"and",
"a",
"second",
"method",
"of",
"birth",
"control",
"during",
"the",
"course",
"of",
"the",
"study",
"and",
"for",
"6",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02510417
|
10:13:treatment,15:22:treatment,32:78:treatment,
|
Received ATG, Campath or other T cell immunosuppressive monoclonal antibodies in the last 28 days
| 3
|
[
"Received",
"ATG",
",",
"Campath",
"or",
"other",
"T",
"cell",
"immunosuppressive",
"monoclonal",
"antibodies",
"in",
"the",
"last",
"28",
"days"
] |
[
0,
1,
0,
1,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03109210
|
1:26:chronic_disease
|
imminent risk for suicide
| 3
|
[
"imminent",
"risk",
"for",
"suicide"
] |
[
2,
2,
2,
2
] |
NCT02335671
|
37:92:treatment,118:123:cancer,161:164:treatment,193:219:treatment
|
Participants must be candidates for definitive local therapy with breast conserving therapy (this takes into account tumor to breast size ratio appropriate for BCS, and the ability to undergo standard radiation therapy post-operatively)
| 3
|
[
"Participants",
"must",
"be",
"candidates",
"for",
"definitive",
"local",
"therapy",
"with",
"breast",
"conserving",
"therapy",
"(",
"this",
"takes",
"into",
"account",
"tumor",
"to",
"breast",
"size",
"ratio",
"appropriate",
"for",
"BCS",
",",
"and",
"the",
"ability",
"to",
"undergo",
"standard",
"radiation",
"therapy",
"post-operatively",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT00338065
|
15:34:chronic_disease
|
Patients with open-angle glaucoma
| 3
|
[
"Patients",
"with",
"open-angle",
"glaucoma"
] |
[
0,
0,
2,
2
] |
NCT02525692
|
103:109:cancer,187:196:treatment,199:211:treatment,239:267:treatment,312:330:treatment,321:330:treatment,336:353:cancer,435:444:treatment,455:462:treatment,520:537:cancer,604:619:treatment,748:760:cancer,781:807:treatment,929:951:cancer,969:984:cancer
|
For Arm A or D: Any number of recurrences are allowable. For Arm B: First recurrence (only) WHO Grade glioma. First recurrence is defined as progression following initial therapy (i.e., radiation ± chemotherapy). For participants who had prior therapy with radiation or chemotherapy for a low-grade glioma, the surgical diagnosis of a high-grade glioma will be considered the first recurrence. For patients who did not get additional treatment following surgery and diagnosis of low-grade glioma, surgical diagnosis of high grade glioma will not be considered the first recurrence. Instead, progression after treatment will be considered first recurrence. For Arm C: Patients must have clinical and/or radiographic evidence of first recurrence of glioblastoma and be eligible for salvage surgical resection as deemed by the site Investigator. For Arm E: Patients must have clinical and/or radiographic evidence of recurrence of diffuse midline glioma defined as a WHO Grade IV glioma involving the pons, thalamus or spinal cord, and be eligible for salvage surgical resection as deemed by the site Investigator
| 3
|
[
"For",
"Arm",
"A",
"or",
"D",
":",
"Any",
"number",
"of",
"recurrences",
"are",
"allowable",
".",
"For",
"Arm",
"B",
":",
"First",
"recurrence",
"(",
"only",
")",
"WHO",
"Grade",
"glioma",
".",
"First",
"recurrence",
"is",
"defined",
"as",
"progression",
"following",
"initial",
"therapy",
"(",
"i.e.",
",",
"radiation",
"±",
"chemotherapy",
")",
".",
"For",
"participants",
"who",
"had",
"prior",
"therapy",
"with",
"radiation",
"or",
"chemotherapy",
"for",
"a",
"low-grade",
"glioma",
",",
"the",
"surgical",
"diagnosis",
"of",
"a",
"high-grade",
"glioma",
"will",
"be",
"considered",
"the",
"first",
"recurrence",
".",
"For",
"patients",
"who",
"did",
"not",
"get",
"additional",
"treatment",
"following",
"surgery",
"and",
"diagnosis",
"of",
"low-grade",
"glioma",
",",
"surgical",
"diagnosis",
"of",
"high",
"grade",
"glioma",
"will",
"not",
"be",
"considered",
"the",
"first",
"recurrence",
".",
"Instead",
",",
"progression",
"after",
"treatment",
"will",
"be",
"considered",
"first",
"recurrence",
".",
"For",
"Arm",
"C",
":",
"Patients",
"must",
"have",
"clinical",
"and/or",
"radiographic",
"evidence",
"of",
"first",
"recurrence",
"of",
"glioblastoma",
"and",
"be",
"eligible",
"for",
"salvage",
"surgical",
"resection",
"as",
"deemed",
"by",
"the",
"site",
"Investigator",
".",
"For",
"Arm",
"E",
":",
"Patients",
"must",
"have",
"clinical",
"and/or",
"radiographic",
"evidence",
"of",
"recurrence",
"of",
"diffuse",
"midline",
"glioma",
"defined",
"as",
"a",
"WHO",
"Grade",
"IV",
"glioma",
"involving",
"the",
"pons",
",",
"thalamus",
"or",
"spinal",
"cord",
",",
"and",
"be",
"eligible",
"for",
"salvage",
"surgical",
"resection",
"as",
"deemed",
"by",
"the",
"site",
"Investigator"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02588326
|
17:37:treatment,
|
Exposure to any investigational drug within 30 days of enrollment
| 3
|
[
"Exposure",
"to",
"any",
"investigational",
"drug",
"within",
"30",
"days",
"of",
"enrollment"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02579161
|
23:34:treatment
|
Patients currently on antibiotics immediately prior to the procedure
| 3
|
[
"Patients",
"currently",
"on",
"antibiotics",
"immediately",
"prior",
"to",
"the",
"procedure"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02025465
|
16:45:chronic_disease,41:44:chronic_disease,95:116:chronic_disease,118:134:chronic_disease,158:173:chronic_disease,176:189:treatment,196:215:treatment
|
A diagnosis of acute coronary syndrome (ACS) made by the admitting ED physician (ST elevation myocardial infarction, non-ST elevation myocardial infarction, unstable angina) (beta blockers are a Class I medications for ACS)
| 3
|
[
"A",
"diagnosis",
"of",
"acute",
"coronary",
"syndrome",
"(",
"ACS",
")",
"made",
"by",
"the",
"admitting",
"ED",
"physician",
"(",
"ST",
"elevation",
"myocardial",
"infarction",
",",
"non-ST",
"elevation",
"myocardial",
"infarction",
",",
"unstable",
"angina",
")",
"(",
"beta",
"blockers",
"are",
"a",
"Class",
"I",
"medications",
"for",
"ACS",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT02373644
|
1:17:chronic_disease
|
Spinal fractures
| 3
|
[
"Spinal",
"fractures"
] |
[
2,
2
] |
NCT02412540
|
26:39:chronic_disease
|
No evidence of any other liver disease by history, screening tests or histological evaluation
| 3
|
[
"No",
"evidence",
"of",
"any",
"other",
"liver",
"disease",
"by",
"history",
",",
"screening",
"tests",
"or",
"histological",
"evaluation"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128100
|
1:20:treatment,
|
Whole body PET scan within 8 weeks of registration
| 3
|
[
"Whole",
"body",
"PET",
"scan",
"within",
"8",
"weeks",
"of",
"registration"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02525029
|
42:61:treatment,63:71:treatment,73:85:treatment,94:106:treatment
|
Unwilling or unable to stop supplemental sex hormone therapy (estrogen, progesterone, and/or testosterone preparations)
| 3
|
[
"Unwilling",
"or",
"unable",
"to",
"stop",
"supplemental",
"sex",
"hormone",
"therapy",
"(",
"estrogen",
",",
"progesterone",
",",
"and/or",
"testosterone",
"preparations",
")"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0
] |
NCT02394704
|
20:38:treatment,77:91:treatment,93:108:treatment,110:120:treatment,126:149:treatment,,212:222:treatment
|
Current use of any psychotropic drugs thought to affect learning, including antipsychotics, anticonvulsants, stimulants, and anti-Parkinsonian drugs. Current is defined as within 2 weeks of testing, 4 weeks for fluoxetine
| 3
|
[
"Current",
"use",
"of",
"any",
"psychotropic",
"drugs",
"thought",
"to",
"affect",
"learning",
",",
"including",
"antipsychotics",
",",
"anticonvulsants",
",",
"stimulants",
",",
"and",
"anti-Parkinsonian",
"drugs",
".",
"Current",
"is",
"defined",
"as",
"within",
"2",
"weeks",
"of",
"testing",
",",
"4",
"weeks",
"for",
"fluoxetine"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03082612
|
45:68:treatment
|
Have completed more than half of prescribed chemotherapy treatments
| 3
|
[
"Have",
"completed",
"more",
"than",
"half",
"of",
"prescribed",
"chemotherapy",
"treatments"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01419561
|
1:13:chronic_disease,,
|
Hyponatremia (sodium<135mmol/L)
| 3
|
[
"Hyponatremia",
"(",
"sodium",
"<",
"135mmol/L",
")"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT02956486
|
1:20:cancer,
|
Malignant neoplasms within 5 years of Screening
| 3
|
[
"Malignant",
"neoplasms",
"within",
"5",
"years",
"of",
"Screening"
] |
[
3,
3,
0,
0,
0,
0,
0
] |
NCT02409888
|
11:32:chronic_disease,53:66:chronic_disease,70:86:chronic_disease,126:150:chronic_disease
|
a serious psychiatric diagnosis (e.g., uncontrolled schizophrenia or major depression) as well as those meeting criteria for organic brain impairment, as measured by the mini-mental status examination section of the DIS-IV will be precluded from study participation
| 3
|
[
"a",
"serious",
"psychiatric",
"diagnosis",
"(",
"e.g.",
",",
"uncontrolled",
"schizophrenia",
"or",
"major",
"depression",
")",
"as",
"well",
"as",
"those",
"meeting",
"criteria",
"for",
"organic",
"brain",
"impairment",
",",
"as",
"measured",
"by",
"the",
"mini-mental",
"status",
"examination",
"section",
"of",
"the",
"DIS-IV",
"will",
"be",
"precluded",
"from",
"study",
"participation"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03121586
|
49:65:chronic_disease
|
Known family or personal history or symptoms of long QT syndrome
| 3
|
[
"Known",
"family",
"or",
"personal",
"history",
"or",
"symptoms",
"of",
"long",
"QT",
"syndrome"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02040610
|
1:10:treatment
|
Bone scan is not required for patients enrolled with a single intermediate risk factor only, but this scan may be obtained at the discretion of the treating physician
| 3
|
[
"Bone",
"scan",
"is",
"not",
"required",
"for",
"patients",
"enrolled",
"with",
"a",
"single",
"intermediate",
"risk",
"factor",
"only",
",",
"but",
"this",
"scan",
"may",
"be",
"obtained",
"at",
"the",
"discretion",
"of",
"the",
"treating",
"physician"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01261728
|
,,,45:58:chronic_disease
|
Evidence of NYHA functional class III or IV heart disease
| 3
|
[
"Evidence",
"of",
"NYHA",
"functional",
"class",
"III",
"or",
"IV",
"heart",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01653093
|
7:29:chronic_disease
|
known circulatory impairment
| 3
|
[
"known",
"circulatory",
"impairment"
] |
[
0,
2,
2
] |
NCT03159936
|
,,101:112:treatment
|
Women of childbearing potential must use effective contraceptive methods in order to participate in tofacitinib clinical studies
| 3
|
[
"Women",
"of",
"childbearing",
"potential",
"must",
"use",
"effective",
"contraceptive",
"methods",
"in",
"order",
"to",
"participate",
"in",
"tofacitinib",
"clinical",
"studies"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02387216
|
,26:50:treatment
|
Not received more than 2 prior systemic therapies
| 3
|
[
"Not",
"received",
"more",
"than",
"2",
"prior",
"systemic",
"therapies"
] |
[
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02446457
|
11:29:chronic_disease,48:66:treatment,,127:142:treatment,146:169:treatment
|
No active autoimmune disease that has required systemic treatment in past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs)
| 3
|
[
"No",
"active",
"autoimmune",
"disease",
"that",
"has",
"required",
"systemic",
"treatment",
"in",
"past",
"2",
"years",
"(",
"i.e",
".",
"with",
"use",
"of",
"disease",
"modifying",
"agents",
",",
"corticosteroids",
"or",
"immunosuppressive",
"drugs",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0
] |
NCT02932410
|
1:58:chronic_disease
|
PAH associated with connective tissue diseases (PAH-aCTD)
| 3
|
[
"PAH",
"associated",
"with",
"connective",
"tissue",
"diseases",
"(",
"PAH-aCTD",
")"
] |
[
2,
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02446886
|
34:51:chronic_disease
|
Patients with a known history of diabetes mellitus
| 3
|
[
"Patients",
"with",
"a",
"known",
"history",
"of",
"diabetes",
"mellitus"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT00924027
|
1:22:cancer
|
lymph node metastases
| 3
|
[
"lymph",
"node",
"metastases"
] |
[
3,
3,
3
] |
NCT02398773
|
32:55:treatment,60:78:cancer,94:122:treatment
|
Patient must NOT have received prior endocrine therapy for metastatic disease (i.e., must be first-line endocrine therapy for metastatic disease)
| 3
|
[
"Patient",
"must",
"NOT",
"have",
"received",
"prior",
"endocrine",
"therapy",
"for",
"metastatic",
"disease",
"(",
"i.e.",
",",
"must",
"be",
"first-line",
"endocrine",
"therapy",
"for",
"metastatic",
"disease",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
3,
3,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02138617
|
46:60:cancer
|
Histological or cytological documentation of adenocarcinoma of the colon or rectum
| 3
|
[
"Histological",
"or",
"cytological",
"documentation",
"of",
"adenocarcinoma",
"of",
"the",
"colon",
"or",
"rectum"
] |
[
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02565901
|
91:100:treatment,124:141:chronic_disease,164:174:treatment
|
patient must be offered and made aware of all Food and Drug Administration (FDA)‐approved treatment options; patients with bone only disease may not have received radium-223
| 3
|
[
"patient",
"must",
"be",
"offered",
"and",
"made",
"aware",
"of",
"all",
"Food",
"and",
"Drug",
"Administration",
"(",
"FDA",
")",
"‐approved",
"treatment",
"options",
";",
"patients",
"with",
"bone",
"only",
"disease",
"may",
"not",
"have",
"received",
"radium-223"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
1
] |
NCT02307058
|
4:17:treatment,25:37:treatment,,92:114:treatment,136:161:treatment
|
An anti-androgen (e.g., bicalutamide at 50 mg per day po) is recommended to start prior to LHRH agonist injection (not recommended for LHRH antagonist injection) and is recommended to not be administered
| 3
|
[
"An",
"anti-androgen",
"(",
"e.g.",
",",
"bicalutamide",
"at",
"50",
"mg",
"per",
"day",
"po",
")",
"is",
"recommended",
"to",
"start",
"prior",
"to",
"LHRH",
"agonist",
"injection",
"(",
"not",
"recommended",
"for",
"LHRH",
"antagonist",
"injection",
")",
"and",
"is",
"recommended",
"to",
"not",
"be",
"administered"
] |
[
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02769611
|
15:32:chronic_disease
|
Patients with acute myocarditis
| 3
|
[
"Patients",
"with",
"acute",
"myocarditis"
] |
[
0,
0,
2,
2
] |
NCT02266329
|
15:36:chronic_disease
|
any period of loss of consciousness
| 3
|
[
"any",
"period",
"of",
"loss",
"of",
"consciousness"
] |
[
0,
0,
0,
2,
2,
2
] |
NCT02584647
|
10:47:treatment
|
Agree to pre and post-treatment tumor biopsies
| 3
|
[
"Agree",
"to",
"pre",
"and",
"post-treatment",
"tumor",
"biopsies"
] |
[
0,
0,
1,
1,
1,
1,
1
] |
NCT02760498
|
,60:78:chronic_disease,93:102:treatment,108:134:treatment,135:145:treatment,174:203:chronic_disease
|
Ongoing or recent (within 5 years) evidence of significant autoimmune disease that required treatment with systemic immunosuppressive treatments, which may suggest risk for immune-related adverse events
| 3
|
[
"Ongoing",
"or",
"recent",
"(",
"within",
"5",
"years",
")",
"evidence",
"of",
"significant",
"autoimmune",
"disease",
"that",
"required",
"treatment",
"with",
"systemic",
"immunosuppressive",
"treatments",
",",
"which",
"may",
"suggest",
"risk",
"for",
"immune-related",
"adverse",
"events"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02570256
|
34:49:chronic_disease
|
diffuse/multiple lesion sites or multiple stroke events
| 3
|
[
"diffuse/multiple",
"lesion",
"sites",
"or",
"multiple",
"stroke",
"events"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT00147056
|
104:113:chronic_disease
|
Symptoms and signs of increased intracranial pressure (e.g., headache, nausea, vomiting, lethargy, and papaedema)
| 3
|
[
"Symptoms",
"and",
"signs",
"of",
"increased",
"intracranial",
"pressure",
"(",
"e.g.",
",",
"headache",
",",
"nausea",
",",
"vomiting",
",",
"lethargy",
",",
"and",
"papaedema",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02323945
|
,,,57:70:chronic_disease
|
Age 18 and 75 years (the latter to reduce likelihood of heart disease)
| 3
|
[
"Age",
"18",
"and",
"75",
"years",
"(",
"the",
"latter",
"to",
"reduce",
"likelihood",
"of",
"heart",
"disease",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT03007745
|
1:10:chronic_disease
|
cirrhosis
| 3
|
[
"cirrhosis"
] |
[
2
] |
NCT02584244
|
39:70:treatment
|
Subjects may have previously received pre-operative radiation therapy
| 3
|
[
"Subjects",
"may",
"have",
"previously",
"received",
"pre-operative",
"radiation",
"therapy"
] |
[
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02585973
|
,159:175:treatment,
|
Not willing to avoid grapefruit, grapefruit juices, grapefruit hybrids, Seville oranges, pummelos, and exotic citrus fruits from 14 days prior to the dose of study medication, throughout the study, and until 2 weeks after the last dose of AZD1775 due to potential CYP3A4 interaction with the study medication
| 3
|
[
"Not",
"willing",
"to",
"avoid",
"grapefruit",
",",
"grapefruit",
"juices",
",",
"grapefruit",
"hybrids",
",",
"Seville",
"oranges",
",",
"pummelos",
",",
"and",
"exotic",
"citrus",
"fruits",
"from",
"14",
"days",
"prior",
"to",
"the",
"dose",
"of",
"study",
"medication",
",",
"throughout",
"the",
"study",
",",
"and",
"until",
"2",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"AZD1775",
"due",
"to",
"potential",
"CYP3A4",
"interaction",
"with",
"the",
"study",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02962427
|
14:42:chronic_disease
|
Diagnosis of post-dural puncture headache based on the International Classification of Headache Disorders
| 3
|
[
"Diagnosis",
"of",
"post-dural",
"puncture",
"headache",
"based",
"on",
"the",
"International",
"Classification",
"of",
"Headache",
"Disorders"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496208
|
1:25:chronic_disease
|
Unstable angina pectoris
| 3
|
[
"Unstable",
"angina",
"pectoris"
] |
[
2,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.